[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650246":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":17,"centralContacts":17,"locations":18,"responsibleParty":42,"collaborators":17,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":17,"eligibilityCriteria":50,"healthyVolunteers":46,"sex":51,"minAge":52,"maxAge":17,"enrollmentInfo":53,"targetDuration":17,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":17,"overallStatus":63,"whyStopped":17,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Voll Medical Technologies Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":9,"interventionNames":11},"Voll Non-Degradable Shoulder Spacer","EXPERIMENTAL",[12],"Device: Voll Non-Degradable Shoulder Spacer",[14],{"type":15,"name":9,"description":9,"armGroupLabels":16,"otherNames":17},"DEVICE",[9],null,[19],{"facility":20,"status":17,"city":21,"state":17,"zip":17,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"Assuta Ashdod Hospital","Ashdod","Israel","IL",{"type":25,"coordinates":26},"Point",[27,28],34.64966,31.79213,{"lat":28,"lon":27},[31,36,39],{"name":32,"role":33,"phone":34,"phoneExt":17,"email":35},"Sahar Boostenay","CONTACT","+972544621243","sahar@vollmedical.com",{"name":37,"role":38,"phone":17,"phoneExt":17,"email":17},"Ran Atzmon, MD","PRINCIPAL_INVESTIGATOR",{"name":40,"role":41,"phone":17,"phoneExt":17,"email":17},"Yariv Goldstein, MD","SUB_INVESTIGATOR",{"type":43,"investigatorFullName":17,"investigatorTitle":17,"investigatorAffiliation":17,"oldNameTitle":17,"oldOrganization":17},"SPONSOR","100650246","voll-non-degradable-shoulder-spacer-fih-study-100650246",false,"NCT07745647","Voll Non-Degradable Shoulder Spacer FIH Study","A Single-Center, Prospective, First-In-Human Study to Evaluate the Initial Safety and Effectiveness of a Non-Degradable Shoulder Spacer in Patients With Symptomatic Massive Rotator Cuff Tears","Inclusion Criteria:\n\n* Full thickness MRCT.\n* Male or female patients ≥ fifty (50) years of age, in general good health, independent, and can comply with all post-operative evaluations and visits.\n\nExclusion Criteria:\n\n* Documented evidence of a history of drug\u002Falcohol abuse within 1 year of enrollment.\n* Concurrent participation in any other investigational clinical study.","ALL","50 Years",{"count":54,"type":55},10,"ESTIMATED","INTERVENTIONAL",[58],"NA","The Voll Non-Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a non-degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).",[61,62],"Massive Rotator Cuff Tears","Massive Rotator Cuff Tear","NOT_YET_RECRUITING","2026-07-29",{"date":66,"type":67},"2026-08-04","ACTUAL",{"date":69,"type":55},"2026-09",{"date":71,"type":55},"2028-09",{"name":5,"class":6},1]